Biocon Ltd has announced a Board of Directors meeting scheduled for August 5, 2026, to approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Concurrently, the company has closed its trading window from July 1, 2026, to August 7, 2026, reopening on August 8, 2026, in line with insider trading regulations. An earnings conference call for analysts and investors is scheduled for August 6, 2026, to discuss the financial performance. The company will provide recordings and transcripts of the call on its website.

Corporate Professionals Capital Pvt Ltd, acting as Manager to the Offer, has submitted a Public Announcement on behalf of Mr. Pravin Kumar Shishodiya and Mr. Punit Shishodiya. They intend to acquire up to 37,70,000 equity shares, representing 26.00% of the equity share capital of Ramgopal Polytex Limited (RPL). The offer price is set at ₹17.10 per equity share. This open offer is being made pursuant to SEBI (SAST) Regulations, 2011. The acquirers have also entered into a Share Purchase Agreement to acquire 45.46% of the equity share capital from the promoter group at ₹9 per share.

VST Tillers Tractors Ltd announced the retirement of Mrs. Siva Kameswari Vissa as an Independent Director. Her retirement is effective from the close of business hours on July 28, 2026, following the completion of her second consecutive term. As a result, she has also ceased to be a Member of the Company's Audit Committee. The Board of Directors expressed sincere appreciation for her valuable guidance, support, and contributions during her tenure.

Pankaj Polymers Ltd has announced its First Extra-ordinary General Meeting (EGM) scheduled for Saturday, August 22, 2026, at 3:00 PM IST. The meeting will be conducted virtually via Video Conferencing/Other Audio Visual Means. Key agenda items include the appointment of M/s. Shilpi Sharma & Co. as Statutory Auditors to fill a casual vacancy and the issuance of up to 8,55,000 equity shares to the non-promoter category on a preferential basis. The notice for the EGM, along with e-voting details, has been dispatched to members and is available on the company's website.

Ameenji Rubber Ltd announced the resignation of its Chief Financial Officer (CFO), Mrs. Tejaswini Kandra. The resignation is effective from the close of working hours on July 28, 2026, and is due to personal reasons. The company has provided further details as per SEBI (LODR) Regulations, 2015, in an attached annexure. The company has requested stakeholders to take this information on record.

RPG Life Sciences Ltd announced its unaudited consolidated and standalone financial results for the quarter ended June 30, 2026. The Board of Directors approved these results during a meeting held on July 28, 2026. The limited review reports from the statutory auditors, SRBC & CO LLP, were also enclosed. The company followed Indian Accounting Standard 34 for interim financial reporting. The filing details the process and confirmation of the results' accuracy based on the review.

Sanofi Consumer Healthcare India Ltd announced that its Board of Directors, in a meeting held on July 28, 2026, has approved the unaudited financial results for the quarter and half-year ended June 30, 2026. The company has submitted these results along with the Limited Review Report from statutory auditors, Price Waterhouse & Co Chartered Accountants LLP, as per SEBI Listing Regulations. The results will be published in newspapers and made available on the company's investor website. The board meeting commenced at 4:00 p.m. and concluded at 6:00 p.m.

Hypersoft Technologies Ltd has announced that its Board of Directors will convene on July 31, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Following this announcement, the trading window for designated employees and promoters, which was closed from the quarter's end, will reopen on August 3, 2026, 48 hours after the results are declared, in compliance with SEBI regulations on insider trading.

TruAlt Bioenergy Ltd announced that its Board of Directors, in a meeting held on July 28, 2026, approved the appointment of Mr. Mallikarjun Bhimappa Dyaberi as the Chairman of the Board. Mr. Dyaberi, already an Independent Director, will serve as Chairman for a period of one year, effective from July 28, 2026. He possesses extensive experience in public administration and holds advanced degrees in Physics, Mathematics, Radio Physics, and Electronics. His career includes significant roles in the Karnataka Administrative Service and Indian Administrative Service, with notable contributions to organizations like NIMHANS and the Karnataka Housing Board. This appointment is expected to leverage his strategic and governance expertise for the company's benefit. Mr. Dyaberi will continue as an Independent Director under his original terms.

Seemax Resources Ltd announced the rejection of its compounding application filed with the Regional Director, North Western Region. The application was related to a violation of Section 185(1) of the Companies Act, 2013, under Section 441 of the same act. The company has received the order and is currently examining its contents to evaluate appropriate legal remedies, including the possibility of filing an appeal or a fresh application. As of the filing date, Seemax Resources stated there is no material impact on its operations, and it will pursue legal recourse as advised.

Indian Renewable Energy Development Agency Ltd (IREDA) has announced that its Board of Directors will convene on August 3, 2026. The primary agenda item is to consider and approve the unaudited financial results for both standalone and consolidated operations for the first quarter ended June 30, 2026. In line with SEBI regulations, the trading window for the company's securities has been closed since July 1, 2026, and will remain shut until 48 hours after the financial results are declared. This closure was previously communicated to the stock exchanges on June 25, 2026.

AGI Greenpac Limited announced robust financial results for Q1 FY27, with revenue from operations growing 14% year-on-year to ₹785 crore. Net profit increased by 12% year-on-year to ₹99 crore. EBITDA, excluding other income, rose 23% to ₹175 crore, achieving healthy margins of 22%. The company is expanding its glass packaging capacity, aiming to reach 2,600 TPD with a new Greenfield plant in Madhya Pradesh. Additionally, AGI Greenpac is entering the aluminium beverage cans segment, with commercial operations targeted for December 2027. Management attributed the performance to an improved product mix, operational efficiencies, and sustained demand.

Styrenix Performance Materials Ltd has announced a Board of Directors meeting scheduled for August 4, 2026. The primary agenda items include the consideration and approval of the standalone and consolidated unaudited financial results for the first quarter ended June 30, 2026. Additionally, the board will consider and declare an interim dividend for the Financial Year 2026-27, if deemed appropriate. The trading window for company insiders has been closed from July 1, 2026, and will reopen 48 hours after the financial results are declared, expected by August 6, 2026.

Sanofi Consumer Healthcare India Ltd announced its unaudited financial results for the quarter and half-year ended June 30, 2026. The Board of Directors approved these results at a meeting held on July 28, 2026. The company has submitted the results along with a Limited Review Report from its statutory auditors, Price Waterhouse & Co Chartered Accountants LLP, as per SEBI Listing Regulations. The results will be published in newspapers and made available on the company's investor relations website.

RPG Life Sciences posted consolidated revenue from operations of ₹195.69 Cr for Q1 FY27 (quarter ended June 30, 2026), up 15.9% YoY (₹168.92 Cr) and 10.6% QoQ (₹176.89 Cr). Consolidated PAT came in at ₹30.76 Cr, up 17.0% YoY (₹26.29 Cr) and a more modest 2.9% QoQ (₹29.90 Cr) — the YoY print is the primary signal here since profit growth outpaced revenue growth, pointing to margin expansion rather than a one-off. Standalone tells an almost identical story (PAT ₹30.57 Cr, EPS ₹18.49 vs consolidated EPS ₹18.60), so the small consolidation delta from the newly formed subsidiary RPG Active Pharma Limited is not yet material to the group numbers. On margins, operating profitability (EBITDA/revenue) improved to roughly 22.1% from ~21.0% a year ago and ~19.2% last quarter, while the net margin held broadly flat at 15.35% (15.1% YoY, 15.8% QoQ) as tax incidence normalised (effective tax rate ~25.8% this quarter vs ~25.8% YoY). Cost of materials consumed (₹37.68 Cr) and employee benefits expense (₹37.76 Cr) grew slower than revenue, the main driver of the operating-margin gain; finance costs rose sharply in percentage terms (₹0.63 Cr vs ₹0.13 Cr YoY) though off a small base, likely tied to working-capital or subsidiary-related funding. There is no consensus or brokerage estimate on record for this stock — it carries no visible formal analyst coverage, so vsStreet is unknown rather than a miss/beat call. Similarly, the company has issued no formal forward guidance in our records or in a web search, so the quarter cannot be graded against a stated management target; management's own press commentary on this result had not been separately released as of this filing. Corporate context this quarter includes the Board approving the unaudited Q1 results on July 28, 2026, the 19th AGM held July 23, 2026, a BRSR sustainability filing, and a July 13, 2026 tie-up with Archerchem to launch Naprosyn ES in India — a new-launch item that is a forward revenue lever rather than a driver of this quarter's print. The Board's December 2025 approval to transfer the API division into wholly-owned subsidiary RPG Active Pharma Limited remains pending regulatory sign-off and is the main structural item to track into subsequent quarters, since it will reshape the standalone/consolidated split once completed.